标题
NLRP3 inflammasome in hepatic diseases: A pharmacological target
作者
关键词
-
出版物
BIOCHEMICAL PHARMACOLOGY
Volume 217, Issue -, Pages 115861
出版商
Elsevier BV
发表日期
2023-10-18
DOI
10.1016/j.bcp.2023.115861
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effectiveness of targeting the NLRP3 inflammasome by using natural polyphenols: A systematic review of implications on health effects
- (2023) Taotao Wang et al. FOOD RESEARCH INTERNATIONAL
- Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review
- (2023) Ashraf Elbahrawy et al. Viruses-Basel
- Acetaminophen-induced hepatotoxicity predominantly via inhibiting Nrf2 antioxidative pathway and activating TLR4-NF-κB-MAPK inflammatory response in mice
- (2023) Xing-Ling Shen et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Mechanisms of non-alcoholic fatty liver disease development in normal-weight individuals
- (2023) Pablo Muriel et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome
- (2023) Qi Shen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of NLRP3 inflammasome in hepatocellular carcinoma: A double-edged sword
- (2023) Ying-Le Tang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Activated Hepatic Stellate Cells (Ito Cells) - Marker of Advanced Fibrosis in Chronic Viral Hepatitis C: A Pilot Study
- (2023) Rada Teodora Sufletel et al. Journal of Gastrointestinal and Liver Diseases
- Relapsing autoimmune inner ear disease with significant response to methotrexate and azathioprine combination therapy: A case report and mini literature review
- (2023) Kuan-Hsuan Huang et al. MEDICINE
- The role of NLRP3 inflammasome in hepatocellular carcinoma
- (2023) Huijie Zhao et al. Frontiers in Pharmacology
- Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome/pyroptosis pathway
- (2023) Irina Cardoso-Lezama et al. BIOCHEMICAL PHARMACOLOGY
- Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease
- (2023) Annabelle S Chidiac et al. Expert Opinion on Drug Metabolism & Toxicology
- Analysis of hepatocellular carcinoma associated with hepatitis B virus
- (2023) Litao Zheng JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Effect of Alcohol Consumption Habits on Early Arterial Aging in Subjects with Metabolic Syndrome and Elevated Serum Uric Acid
- (2023) Alma Čypienė et al. Nutrients
- The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways
- (2023) Shahrzad Shoraka et al. Frontiers in Microbiology
- T memory stem cell characteristics in autoimmune diseases and their promising therapeutic values
- (2023) Pooria Fazeli et al. Frontiers in Immunology
- Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma
- (2023) Zhuoran Wang et al. Frontiers in Oncology
- Role of NLRP3 inflammasome activation in HCC cell progression
- (2023) Bingling Dai et al. Heliyon
- Modulatory Properties of Food and Nutraceutical Components Targeting NLRP3 Inflammasome Activation
- (2022) Mattia Spano et al. Nutrients
- Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy
- (2022) Konstantinos Arvanitakis et al. Cancers
- Curcumin mitigates aflatoxin B1-induced liver injury via regulating the NLRP3 inflammasome and Nrf2 signaling pathway
- (2022) Yingjie Wang et al. FOOD AND CHEMICAL TOXICOLOGY
- NLRP3 promotes immune escape by regulating immune checkpoints: A pan-cancer analysis
- (2022) Yue Ding et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dimethyl fumarate ameliorates autoimmune hepatitis in mice by blocking NLRP3 inflammasome activation
- (2022) Fu-li Shi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- When underlying biology threatens the randomization principle — initial gout flares of urate-lowering therapy
- (2022) Hyon K. Choi et al. Nature Reviews Rheumatology
- Thymol Alleviates LPS-Induced Liver Inflammation and Apoptosis by Inhibiting NLRP3 Inflammasome Activation and the AMPK-mTOR-Autophagy Pathway
- (2022) Xiujing Dou et al. Nutrients
- The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity
- (2022) Stavros P. Papadakos et al. Cancers
- NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease
- (2022) Yanling Guan et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model
- (2022) Eduardo E. Vargas-Pozada et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interleukin-18 in metabolism: From mice physiology to human diseases
- (2022) Emmanuel Somm et al. Frontiers in Endocrinology
- Hesperidin methyl chalcone ameliorates lipid metabolic disorders by activating lipase activity and increasing energy metabolism
- (2022) Songsong Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Attenuation of hepatic fibrosis by p-Coumaric acid via modulation of NLRP3 inflammasome activation in C57BL/6 mice
- (2022) Thi My Tien Truong et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Unraveling the Molecular Mechanisms Involved in HCV-Induced Carcinogenesis
- (2022) Tania Guadalupe Heredia-Torres et al. Viruses-Basel
- Inhibition of hepatic NLRP3 inflammasome ameliorates non-alcoholic steatohepatitis/hepatitis B - induced hepatic injury
- (2022) Feng Chen et al. Clinics and Research in Hepatology and Gastroenterology
- Significance of elevated serum and hepatic NOD-like receptor pyrin domain containing 3 (NLRP3) in hepatitis C virus-related liver disease
- (2022) Hoda El Aggan et al. Scientific Reports
- Anti-Inflammatory Effects of Rosmarinic Acid-Loaded Nanovesicles in Acute Colitis through Modulation of NLRP3 Inflammasome
- (2021) Sonia Marinho et al. Biomolecules
- Bavachin enhances NLRP3 inflammasome activation induced by ATP or nigericin and causes idiosyncratic hepatotoxicity
- (2021) Nan Qin et al. Frontiers of Medicine
- Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases
- (2021) Guang-Ming Ren et al. Science Immunology
- Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies
- (2021) Mohammad Ghanbari et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial
- (2021) Zahra Namkhah et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- NLRP3 Deficiency in Hepatocellular Carcinoma Enhances Surveillance of NK-92 through a Modulation of MICA/B
- (2021) Hwan Hee Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fructose and the Liver
- (2021) Pablo Muriel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The NLRP3 inflammasome mediates liver failure by activating procaspase-1 and pro-IL-1 β and regulating downstream CD40-CD40L signaling
- (2021) Zenghui Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Role of the Inflammasome in Liver Disease
- (2021) Marcelle de Carvalho Ribeiro et al. Annual Review of Pathology-Mechanisms of Disease
- FNDC5 induces M2 macrophage polarization and promotes hepatocellular carcinoma cell growth by affecting the PPARγ/NF-κB/NLRP3 pathway
- (2021) Huayuan Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial
- (2021) Fatemeh Naeini et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- A new perspective on NAFLD: Focusing on lipid droplets
- (2021) Eleonora Scorletti et al. JOURNAL OF HEPATOLOGY
- Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study
- (2021) Xuan Zhu et al. Clinics and Research in Hepatology and Gastroenterology
- Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD
- (2020) Andreea-Manuela Mirea et al. INFLAMMATION
- Pterostilbene Improves Hepatic Lipid Accumulation via the MiR-34a/Sirt1/SREBP-1 Pathway in Fructose-Fed Rats
- (2020) Wen-Yuan Wu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
- (2020) Sudeep Tanwar et al. WORLD JOURNAL OF GASTROENTEROLOGY
- RIPK3 orchestrates fatty acid metabolism in tumor-associated macrophages and hepatocarcinogenesis
- (2020) Lei Wu et al. Cancer Immunology Research
- Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice
- (2020) Lívia Pimentel de Sant'Ana et al. Frontiers in Immunology
- Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation
- (2020) Wen-hui Xie et al. INFLAMMATION RESEARCH
- NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF
- (2020) Yanhong Jia et al. MOLECULAR IMMUNOLOGY
- FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation
- (2020) Jun Jacob Hu et al. NATURE IMMUNOLOGY
- Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases
- (2020) Wei Shi et al. Cell Death & Disease
- Reactive Oxygen Species and Redox Signaling in Chronic Kidney Disease
- (2020) Maria V. Irazabal et al. Cells
- NLRP6 exerts a protective role via NF-kB with involvement of CCL20 in a mouse model of alcoholic hepatitis
- (2020) Xiaoyu Ji et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial
- (2020) Zahra Yari et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Baicalin promotes liver regeneration after acetaminophen-induced liver injury by inducing NLRP3 inflammasome activation
- (2020) Liang Shi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis
- (2020) Susanne Gaul et al. JOURNAL OF HEPATOLOGY
- Metabolic liver disease in diabetes – From mechanisms to clinical trials
- (2020) Bedair Dewidar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis
- (2020) Bernat Baeza-Raja et al. PLoS One
- Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis
- (2020) Antje Mohs et al. JOURNAL OF HEPATOLOGY
- Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects
- (2020) Marina Galicia-Moreno et al. Antioxidants
- NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice
- (2020) Xianfei Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma
- (2020) Yunfan Sun et al. CELL
- Lactate and TGF‐β antagonistically regulate inflammasome activation in the tumor microenvironment
- (2020) Cheng‐e Tu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver
- (2020) Erika Ramos-Tovar et al. Antioxidants
- Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway
- (2020) Koji Ishida et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Sestrin2 protects against bavachin induced ER stress through AMPK/mTORC1 signaling pathway in HepG2 cells
- (2020) Ying Yang et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Systematic Review of Published Data on Herb Induced Liver Injury
- (2019) Jung-Hwan Byeon et al. JOURNAL OF ETHNOPHARMACOLOGY
- Trichloroethene metabolite dichloroacetyl chloride induces apoptosis and compromises phagocytosis in Kupffer Cells: Activation of inflammasome and MAPKs
- (2019) Hui Wang et al. PLoS One
- Modulation of calcium signaling pathway by hepatitis C virus core protein stimulates NLRP3 inflammasome activation
- (2019) Amina A. Negash et al. PLoS Pathogens
- Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis
- (2019) Ning-Ping Zhang et al. LABORATORY INVESTIGATION
- Interleukin-1 Receptor Antagonist Modulates Liver Inflammation and Fibrosis in Mice in a Model-Dependent Manner
- (2019) Raphael Meier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
- (2019) Lijun Liao et al. GUT
- rhIL-1Ra reduces hepatocellular apoptosis in mice with acute liver failure mainly by inhibiting the activities of Kupffer cells
- (2019) Xiaolan Yu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout
- (2019) Zoltán Szekanecz et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Microbiota as a cornerstone in the development of primary sclerosing cholangitis: paving the path for translational diagnostic and therapeutic approaches
- (2019) Catherine Mooser et al. GUT
- Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high‐fat high cholesterol diet via regulating NF‐κB and NLRP3 inflammasome pathway
- (2019) Yuanling Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hepatitis B core antigen can regulate NLRP3 inflammasome pathway in HepG2 cells
- (2019) Xiaolin Ding et al. JOURNAL OF MEDICAL VIROLOGY
- British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
- (2019) Michael Huw Chapman et al. GUT
- Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice
- (2019) Aleksandar Arsenijevic et al. Frontiers in Immunology
- Free radicals, antioxidants, nuclear factor‐E2‐related factor‐2 and liver damage
- (2019) Erika Ramos‐Tovar et al. JOURNAL OF APPLIED TOXICOLOGY
- Host inflammasome defense mechanisms and bacterial pathogen evasion strategies
- (2019) Susan M Brewer et al. CURRENT OPINION IN IMMUNOLOGY
- Redox regulation of hepatic NLRP3 inflammasome activation and immune dysregulation in trichloroethene-mediated autoimmunity
- (2019) Hui Wang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pharmacological Inhibitors of the NLRP3 Inflammasome
- (2019) Ayesha Zahid et al. Frontiers in Immunology
- Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress
- (2019) Shi Zilu et al. Aging-US
- Herbal medicines for the liver
- (2019) Eduardo E. Vargas-Pozada et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease
- (2019) Seyed Reza Mirhafez et al. INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
- Clinicopathological features of Bu Gu Zhi‐induced liver injury, a long‐term follow‐up cohort study
- (2019) Lan Wang et al. LIVER INTERNATIONAL
- NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway
- (2019) Durgesh Kumar Dwivedi et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Baicalein and baicalin alleviate acetaminophen-induced liver injury by activating Nrf2 antioxidative pathway: The involvement of ERK1/2 and PKC
- (2018) Liang Shi et al. BIOCHEMICAL PHARMACOLOGY
- Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice
- (2018) Xianhong Du et al. Cellular & Molecular Immunology
- Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
- (2018) Paschalis Paschos et al. Current Vascular Pharmacology
- The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation
- (2018) Adam Molyvdas et al. CYTOKINE
- Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression
- (2018) Mi Jeong Heo et al. GUT
- Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment
- (2018) Jingying Zhang et al. HEPATOLOGY
- A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
- (2018) Kris V. Kowdley et al. HEPATOLOGY
- Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice
- (2018) Bing Xu et al. JOURNAL OF HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Globalization and the Changing Epidemiology of Hepatitis A Virus
- (2018) Kathryn H. Jacobsen Cold Spring Harbor Perspectives in Medicine
- NOD-Like Receptor Protein 3 Inflammasome-Dependent IL-1β Accelerated ConA-Induced Hepatitis
- (2018) Jingyun Luan et al. Frontiers in Immunology
- Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release
- (2018) Junjiang Pan et al. CELLULAR IMMUNOLOGY
- Burden of Liver Diseases in the World
- (2018) Sumeet K. Asrani et al. JOURNAL OF HEPATOLOGY
- Mitochondrial dysfunction-related lipid changes occur in non-alcoholic fatty liver disease progression
- (2018) Kang-Yu Peng et al. JOURNAL OF LIPID RESEARCH
- New mitochondrial DNA synthesis enables NLRP3 inflammasome activation
- (2018) Zhenyu Zhong et al. NATURE
- Alcoholic liver disease
- (2018) Helmut K. Seitz et al. Nature Reviews Disease Primers
- Repression of TXNIP-NLRP3 axis restores intestinal barrier function via inhibition of myeloperoxidase activity and oxidative stress in nonalcoholic steatohepatitis
- (2018) Ru-Xue Bai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline
- (2017) Lars Aabakken et al. ENDOSCOPY
- Hepatic nucleotide binding oligomerization domain- like receptors pyrin domain-containing 3 inflammasomes are associated with the histologic severity of non-alcoholic fatty liver disease
- (2017) Hironori Mitsuyoshi et al. HEPATOLOGY RESEARCH
- NLRP3 Deletion Inhibits the Non-alcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic Acid
- (2017) Can Cai et al. INFLAMMATION
- Inflammasome activation and assembly at a glance
- (2017) Ankit Malik et al. JOURNAL OF CELL SCIENCE
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
- (2017) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- Primary sclerosing cholangitis – a comprehensive review
- (2017) Tom H. Karlsen et al. JOURNAL OF HEPATOLOGY
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance
- (2017) Wen-Jun Su et al. Journal of Neuroinflammation
- Clinical Trial Design for Alcoholic Hepatitis
- (2017) Gyongyi Szabo SEMINARS IN LIVER DISEASE
- Mitochondrial ROS induced by chronic ethanol exposure promote hyper-activation of the NLRP3 inflammasome
- (2017) Laura R. Hoyt et al. Redox Biology
- Hepatitis C virus infection
- (2017) Michael P. Manns et al. Nature Reviews Disease Primers
- Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
- (2017) Irene Pierantonelli et al. Scientific Reports
- BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination
- (2017) Do-Wan Shim et al. Scientific Reports
- Angiotensin-(1–7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation
- (2016) Shuang-Ming Cai et al. ANTIOXIDANTS & REDOX SIGNALING
- Galectin-3 regulates inflammasome activation in cholestatic liver injury
- (2016) Jijing Tian et al. FASEB JOURNAL
- Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease
- (2016) Terence N. Bukong et al. HEPATOLOGY
- Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
- (2016) Chuansheng Guo et al. IMMUNITY
- K + Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria
- (2016) Christina J. Groß et al. IMMUNITY
- Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism
- (2016) Xingyong Wan et al. JOURNAL OF HEPATOLOGY
- Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
- (2016) Sepideh Rahmani et al. PHYTOTHERAPY RESEARCH
- Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma
- (2016) Te-Sheng Chang et al. PLoS One
- Hepatitis E vaccine: WHO position paper, May 2015 – Recommendations
- (2016) WHO VACCINE
- Baicalin Attenuates IL-17-Mediated Acetaminophen-Induced Liver Injury in a Mouse Model
- (2016) Chia-Chih Liao et al. PLoS One
- Experimental models of liver fibrosis
- (2015) Sara Crespo Yanguas et al. ARCHIVES OF TOXICOLOGY
- Macrophage autophagy protects against liver fibrosis in mice
- (2015) Jasper Lodder et al. Autophagy
- Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice
- (2015) Arvin Iracheta-Vellve et al. JOURNAL OF HEPATOLOGY
- Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice
- (2015) Kele Cui et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Autoimmune hepatitis
- (2015) JOURNAL OF HEPATOLOGY
- Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease
- (2015) Jan Petrasek et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Silymarin Inhibits the Progression of Fibrosis in the Early Stages of Liver Injury in CCl4-Treated Rats
- (2015) Simona Clichici et al. JOURNAL OF MEDICINAL FOOD
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
- (2015) Hong-Mei Yan et al. PLoS One
- ER stress induces NLRP3 inflammasome activation and hepatocyte death
- (2015) C Lebeaupin et al. Cell Death & Disease
- Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
- (2014) Alvin Lu et al. CELL
- Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH
- (2014) George N. Ioannou et al. JOURNAL OF LIPID RESEARCH
- NLRP3 inflammasome activation is required for fibrosis development in NAFLD
- (2014) Alexander Wree et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease
- (2014) Cosmin S. Voican et al. LIVER INTERNATIONAL
- Rutin modulates ASC expression in NLRP3 inflammasome: a study in alcohol and cerulein-induced rat model of pancreatitis
- (2014) Ravikumar Aruna et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Luteoloside Suppresses Proliferation and Metastasis of Hepatocellular Carcinoma Cells by Inhibition of NLRP3 Inflammasome
- (2014) Shao-hua Fan et al. PLoS One
- A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States
- (2014) Marissa Blieden et al. Expert Review of Clinical Pharmacology
- Mechanism of interleukin-1β-induced proliferation in rat hepatic stellate cells from different levels of signal transduction
- (2013) Zhang Yaping et al. APMIS
- Psoralea corylifolia L. (Buguchi) — Folklore to modern evidence: Review
- (2013) Bhawna Chopra et al. FITOTERAPIA
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
- (2013) Alexander Wree et al. HEPATOLOGY
- P2X7 blockade attenuates mouse liver fibrosis
- (2013) CHANGSHAN HUANG et al. Molecular Medicine Reports
- Interleukin-1β upregulates matrix metalloproteinase-13 gene expression via c-Jun N-terminal kinase and p38 MAPK pathways in rat hepatic stellate cells
- (2013) NING TANG et al. Molecular Medicine Reports
- Caspase-1 as a Central Regulator of High Fat Diet-Induced Non-Alcoholic Steatohepatitis
- (2013) Laura J. Dixon et al. PLoS One
- Involvement of oxidative stress and immune- and inflammation-related factors in azathioprine-induced liver injury
- (2013) Kentaro Matsuo et al. TOXICOLOGY LETTERS
- IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease
- (2013) Amina A. Negash et al. PLoS Pathogens
- Current status of inflammasome blockers as anti-inflammatory drugs
- (2012) Gloria López-Castejón et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice
- (2012) Kouichi Miura et al. HEPATOLOGY
- Cell Volume Regulation Modulates NLRP3 Inflammasome Activation
- (2012) Vincent Compan et al. IMMUNITY
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis
- (2012) Kenichi Shimada et al. IMMUNITY
- IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
- (2012) Jan Petrasek et al. JOURNAL OF CLINICAL INVESTIGATION
- Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis
- (2012) Laura J Dixon et al. LABORATORY INVESTIGATION
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- (2012) Jorge Henao-Mejia et al. NATURE
- Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages
- (2011) Nadia M. Luheshi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
- (2011) Derrick M. Van Rooyen et al. GASTROENTEROLOGY
- Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice
- (2011) Yehuda Kamari et al. JOURNAL OF HEPATOLOGY
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- Role of the Nalp3 inflammasome in acetaminophen-induced sterile inflammation and liver injury
- (2011) C. David Williams et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
- (2010) Kouichi Miura et al. GASTROENTEROLOGY
- Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure
- (2010) Chunli Yan et al. LIVER INTERNATIONAL
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial
- (2009) Manal F. Abdelmalek et al. HEPATOLOGY
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
- (2009) Mohamed Lamkanfi et al. JOURNAL OF CELL BIOLOGY
- Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease
- (2009) Noritaka Takatsu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice
- (2008) Rebeca Salguero Palacios et al. LABORATORY INVESTIGATION
- RelA Ser276 Phosphorylation Is Required for Activation of a Subset of NF- B-Dependent Genes by Recruiting Cyclin-Dependent Kinase 9/Cyclin T1 Complexes
- (2008) D. E. Nowak et al. MOLECULAR AND CELLULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started